rafapress / Shutterstock.com

18 September 2024FeaturesUnified Patent CourtJan Phillip Rektorsche, Matthew Royle

Takeaways from landmark UPC decision: Novartis v Celltrion

A recent UPC ruling involving Novartis has major implications for determining jurisdiction, claim interpretation and imminent infringement, as Jan Phillip Rektorschek and Matthew Royle of Taylor Wessing explain.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Unified Patent Court

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers

2 September 2024 A vocal advocate of greater UPC transparency, Freshfields’ Christopher Stothers shares his views on the court’s journey so far, and why it is still so exciting.

Unified Patent Court

DexCom suffers second patent revocation at hands of UPC

17 September 2024 The court rejected the medical device company’s auxiliary requests and nixed patent in 17 territories although it seems receptive to these amendments in general, say Laura Orlando and Rachel Montagnon of Herbert Smith Freehills

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

ABG boosts European patent offering with Barcelona hire

Navigating IP challenges in the wearable tech space

DexCom suffers second patent revocation at hands of UPC

Q&A: Counsel on leading Paltalk’s $65.7m win against Cisco

Plastic evolution: how Lego is using IP to build a more sustainable brand

‘You need a lot of time’: Bardehle Pagenberg's Tilman Müller on the UPC

How an Academy Award-winning makeup pro helped win rare $30.5m beauty trial

Takeaways from landmark UPC decision: Novartis v Celltrion

More on this story

Editor's picks

Editor's picks

More articles